Structure-based ligand discovery: elaborating fragment hits in silico
<p>The high attrition rates of drug discovery have been a key motivation for the development of computational methods to design better, safer, more promising molecules. Hit-to-lead development is often driven by the subjective decisions of medicinal chemists. There is growing interest in devel...
| Huvudupphovsman: | |
|---|---|
| Övriga upphovsmän: | |
| Materialtyp: | Lärdomsprov |
| Språk: | English |
| Publicerad: |
2019
|